Trenzyme receives approval for biosafety level 2 (BSL-2)
Trenzyme is a service provider offering customer specific solutions in the areas of molecular biology / biochemistry / generation of cell lines. Trenzyme's international clientele consists predominantly of pharmaceutical and biotech companies, for whom customized services have been provided successfully for more than 9 years.
Classical projects range from DNA cloning / gene synthesis / mutagenesis by means of expression in different systems (E.coli, yeast, insect cells, mammal cells) to protein purification.
Trenzyme is exclusively financed by private means and is constantly expanding its clientele. Over the last couple of years the company has experienced solid revenue growth.
Further Information is available at www.trenzyme.com